Lakewood-Amedex Biotherapeutics CEO presents at H.C. Wainwright Global Investment Conference

PUBT · 1d ago
Lakewood-Amedex Biotherapeutics CEO presents at H.C. Wainwright Global Investment Conference
  • Lakewood-Amedex Biotherapeutics will present virtually at the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 14-16, 2026.
  • CEO Kelvin Cooper is scheduled for one-on-one meetings with registered investors and potential partners during the conference.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lakewood-Amedex Biotherapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY41881) on September 08, 2026, and is solely responsible for the information contained therein.